List of Chapters/Sections(Table Of Content)
1 Live-type Poultry Vaccine Market Overview
1.1 Product Overview and Scope of Live-type Poultry Vaccine
1.2 Live-type Poultry Vaccine Segment by Type
1.2.1 Global Live-type Poultry Vaccine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Newcastle Disease Vaccine
1.2.3 Infectious Bronchitis Vaccine
1.2.4 Fowl Pox Vaccine
1.2.5 Marek?s Disease Vaccine
1.2.6 Fowl Typhoid Vaccine
1.2.7 Live Coccidiosis Vaccine
1.2.8 Other
1.3 Live-type Poultry Vaccine Segment by Application
1.3.1 Global Live-type Poultry Vaccine Sales Comparison by Application: (2022-2028)
1.3.2 Chicken
1.3.3 Other Poultry
1.4 Global Live-type Poultry Vaccine Market Size Estimates and Forecasts
1.4.1 Global Live-type Poultry Vaccine Revenue 2017-2028
1.4.2 Global Live-type Poultry Vaccine Sales 2017-2028
1.4.3 Live-type Poultry Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Live-type Poultry Vaccine Market Competition by Manufacturers
2.1 Global Live-type Poultry Vaccine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Live-type Poultry Vaccine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Live-type Poultry Vaccine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Live-type Poultry Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Live-type Poultry Vaccine Market Competitive Situation and Trends
2.5.1 Live-type Poultry Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Live-type Poultry Vaccine Players Market Share by Revenue
2.5.3 Global Live-type Poultry Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Live-type Poultry Vaccine Retrospective Market Scenario by Region
3.1 Global Live-type Poultry Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Live-type Poultry Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Live-type Poultry Vaccine Market Facts & Figures by Country
3.3.1 North America Live-type Poultry Vaccine Sales by Country
3.3.2 North America Live-type Poultry Vaccine Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Live-type Poultry Vaccine Market Facts & Figures by Country
3.4.1 Europe Live-type Poultry Vaccine Sales by Country
3.4.2 Europe Live-type Poultry Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Live-type Poultry Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Live-type Poultry Vaccine Sales by Region
3.5.2 Asia Pacific Live-type Poultry Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Live-type Poultry Vaccine Market Facts & Figures by Country
3.6.1 Latin America Live-type Poultry Vaccine Sales by Country
3.6.2 Latin America Live-type Poultry Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Live-type Poultry Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Live-type Poultry Vaccine Sales by Country
3.7.2 Middle East and Africa Live-type Poultry Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Live-type Poultry Vaccine Historic Market Analysis by Type
4.1 Global Live-type Poultry Vaccine Sales Market Share by Type (2017-2022)
4.2 Global Live-type Poultry Vaccine Revenue Market Share by Type (2017-2022)
4.3 Global Live-type Poultry Vaccine Price by Type (2017-2022)
5 Global Live-type Poultry Vaccine Historic Market Analysis by Application
5.1 Global Live-type Poultry Vaccine Sales Market Share by Application (2017-2022)
5.2 Global Live-type Poultry Vaccine Revenue Market Share by Application (2017-2022)
5.3 Global Live-type Poultry Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 MERCK
6.1.1 MERCK Corporation Information
6.1.2 MERCK Description and Business Overview
6.1.3 MERCK Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 MERCK Live-type Poultry Vaccine Product Portfolio
6.1.5 MERCK Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Boehringer Ingelheim Live-type Poultry Vaccine Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 ELANCO
6.3.1 ELANCO Corporation Information
6.3.2 ELANCO Description and Business Overview
6.3.3 ELANCO Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 ELANCO Live-type Poultry Vaccine Product Portfolio
6.3.5 ELANCO Recent Developments/Updates
6.4 QYH BIOTECH
6.4.1 QYH BIOTECH Corporation Information
6.4.2 QYH BIOTECH Description and Business Overview
6.4.3 QYH BIOTECH Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 QYH BIOTECH Live-type Poultry Vaccine Product Portfolio
6.4.5 QYH BIOTECH Recent Developments/Updates
6.5 CEVA
6.5.1 CEVA Corporation Information
6.5.2 CEVA Description and Business Overview
6.5.3 CEVA Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.5.4 CEVA Live-type Poultry Vaccine Product Portfolio
6.5.5 CEVA Recent Developments/Updates
6.6 ZOETIS
6.6.1 ZOETIS Corporation Information
6.6.2 ZOETIS Description and Business Overview
6.6.3 ZOETIS Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.6.4 ZOETIS Live-type Poultry Vaccine Product Portfolio
6.6.5 ZOETIS Recent Developments/Updates
6.7 Vaxxinova
6.6.1 Vaxxinova Corporation Information
6.6.2 Vaxxinova Description and Business Overview
6.6.3 Vaxxinova Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Vaxxinova Live-type Poultry Vaccine Product Portfolio
6.7.5 Vaxxinova Recent Developments/Updates
6.8 PULIKE
6.8.1 PULIKE Corporation Information
6.8.2 PULIKE Description and Business Overview
6.8.3 PULIKE Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.8.4 PULIKE Live-type Poultry Vaccine Product Portfolio
6.8.5 PULIKE Recent Developments/Updates
6.9 PHIBRO ANIMAL HEALTH CORPORATION
6.9.1 PHIBRO ANIMAL HEALTH CORPORATION Corporation Information
6.9.2 PHIBRO ANIMAL HEALTH CORPORATION Description and Business Overview
6.9.3 PHIBRO ANIMAL HEALTH CORPORATION Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.9.4 PHIBRO ANIMAL HEALTH CORPORATION Live-type Poultry Vaccine Product Portfolio
6.9.5 PHIBRO ANIMAL HEALTH CORPORATION Recent Developments/Updates
6.10 JINYU BIOTECHNOLOGY
6.10.1 JINYU BIOTECHNOLOGY Corporation Information
6.10.2 JINYU BIOTECHNOLOGY Description and Business Overview
6.10.3 JINYU BIOTECHNOLOGY Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.10.4 JINYU BIOTECHNOLOGY Live-type Poultry Vaccine Product Portfolio
6.10.5 JINYU BIOTECHNOLOGY Recent Developments/Updates
6.11 HARBIN PHARMACEUTICAL GROUP
6.11.1 HARBIN PHARMACEUTICAL GROUP Corporation Information
6.11.2 HARBIN PHARMACEUTICAL GROUP Live-type Poultry Vaccine Description and Business Overview
6.11.3 HARBIN PHARMACEUTICAL GROUP Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.11.4 HARBIN PHARMACEUTICAL GROUP Live-type Poultry Vaccine Product Portfolio
6.11.5 HARBIN PHARMACEUTICAL GROUP Recent Developments/Updates
6.12 MEVAC
6.12.1 MEVAC Corporation Information
6.12.2 MEVAC Live-type Poultry Vaccine Description and Business Overview
6.12.3 MEVAC Live-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.12.4 MEVAC Live-type Poultry Vaccine Product Portfolio
6.12.5 MEVAC Recent Developments/Updates
7 Live-type Poultry Vaccine Manufacturing Cost Analysis
7.1 Live-type Poultry Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Live-type Poultry Vaccine
7.4 Live-type Poultry Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Live-type Poultry Vaccine Distributors List
8.3 Live-type Poultry Vaccine Customers
9 Live-type Poultry Vaccine Market Dynamics
9.1 Live-type Poultry Vaccine Industry Trends
9.2 Live-type Poultry Vaccine Market Drivers
9.3 Live-type Poultry Vaccine Market Challenges
9.4 Live-type Poultry Vaccine Market Restraints
10 Global Market Forecast
10.1 Live-type Poultry Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Live-type Poultry Vaccine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Live-type Poultry Vaccine by Type (2023-2028)
10.2 Live-type Poultry Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Live-type Poultry Vaccine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Live-type Poultry Vaccine by Application (2023-2028)
10.3 Live-type Poultry Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Live-type Poultry Vaccine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Live-type Poultry Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
